Cargando…

Effects of BAK-free travoprost treatment for 3 years in patients with normal tension glaucoma

BACKGROUND: The purpose of this study was to evaluate the effects of benzalkonium (BAK)-free travoprost monotherapy administered for 3 years on intraocular pressure and visual field performance. METHODS: The intraocular pressure of 76 patients with normal tension glaucoma was monitored every 1–3 mon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Inoue, Kenji, Iwasa, Mayumi, Wakakura, Masato, Tomita, Goji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2012
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3429289/ https://www.ncbi.nlm.nih.gov/pubmed/22969276 http://dx.doi.org/10.2147/OPTH.S33816

Ejemplares similares

Effect of five years of treatment with nipradilol eye drops in patients with normal tension glaucoma
por: Inoue, Kenji, et al.
Publicado: (2011)

Effects of tafluprost treatment for 3 years in patients with normal-tension glaucoma
por: Inoue, Kenji, et al.
Publicado: (2013)

Ocular hypotensive effect and safety of travoprost 0.004%/timolol maleate 0.5% fixed combination after change of treatment regimen from β-blockers and prostaglandin analogs
por: Inoue, Kenji, et al.
Publicado: (2012)

First experience with BAK-free travoprost 0.004% in topical glaucoma medication
por: Gado, Ahmed Salah, et al.
Publicado: (2012)

Effects of treatment with bimatoprost 0.03% for 3 years in patients with normal-tension glaucoma
por: Inoue, Kenji, et al.
Publicado: (2014)

The diurnal and nocturnal effects of travoprost in normal-tension glaucoma
por: Seibold, Leonard K, et al.
Publicado: (2014)

Ocular surface disease in patients with glaucoma or ocular hypertension treated with either BAK-preserved latanoprost or BAK-free travoprost
por: Katz, Gregory, et al.
Publicado: (2010)

Effect of travoprost on 24-hour intraocular pressure in normal tension glaucoma
por: Nomura, Yuya, et al.
Publicado: (2010)

Efficacy and patient tolerability of travoprost BAK-free solution in patients with open-angle glaucoma and ocular hypertension
por: Mirza, Sophia K, et al.
Publicado: (2010)

Ocular Surface Disease with BAK preserved Travoprost and Polyquaternium 1(Polyquad) preserved Travoprost
por: Kumar, Suresh, et al.
Publicado: (2019)

Iris and periocular adverse reactions to bimatoprost in Japanese patients with glaucoma or ocular hypertension
por: Inoue, Kenji, et al.
Publicado: (2012)

Sustainability of Intraocular Pressure Reduction of Travoprost Ophthalmic Solution in Subjects with Normal Tension Glaucoma
por: Naito, Tomoko, et al.
Publicado: (2016)

Short-Term Efficacy and Safety of Omidenepag Isopropyl in Patients with Normal-Tension Glaucoma
por: Inoue, Kenji, et al.
Publicado: (2020)

Effects of unoprostone on diurnal variation of intraocular pressure in healthy volunteers
por: Inoue, Kenji, et al.
Publicado: (2011)

Ocular hypotensive effect, preservation of visual fields, and safety of adding dorzolamide to prostaglandin therapy for twelve months
por: Inoue, Kenji, et al.
Publicado: (2011)

Efficacy of travoprost for the treatment of patients with glaucoma
por: Zhang, Xiu-Li, et al.
Publicado: (2019)

Efficacy, safety, and improved tolerability of travoprost BAK-free ophthalmic solution compared with prior prostaglandin therapy
por: Henry, J Charles, et al.
Publicado: (2008)

Assessment of ocular hypotensive effect and safety 12 months after changing from an unfixed combination to a latanoprost 0.005% + timolol maleate 0.5% fixed combination
por: Inoue, Kenji, et al.
Publicado: (2012)

A comfort comparison of travoprost BAK-free 0.004% versus latanoprost 0.005% in patients with primary open-angle glaucoma or ocular hypertension
por: Godfrey, David A, et al.
Publicado: (2009)

A randomized crossover study comparing tafluprost 0.005% with travoprost 0.004% in patients with normal-tension glaucoma
por: Mizoguchi, Takanori, et al.
Publicado: (2012)

Travoprost with sofZia® preservative system lowered intraocular pressure of Japanese normal tension glaucoma with minimal side effects
por: Mizoue, Shiro, et al.
Publicado: (2014)

Effect on Intraocular Pressure of Switching from Latanoprost and Travoprost Monotherapy to Timolol Fixed Combinations in Patients with Normal-Tension Glaucoma
por: Igarashi, Ryoko, et al.
Publicado: (2014)

Efficacy, safety, and tolerability of travoprost 0.004% BAK-free versus prior treatment with latanoprost 0.005% in Japanese patients
por: Miyashiro, Michael J, et al.
Publicado: (2010)

Comparison of Optical Coherence Tomography Angiography and Laser Speckle Flowgraphy for the Diagnosis of Normal-Tension Glaucoma
por: Takeyama, Asuka, et al.
Publicado: (2018)

Factors Related to a Right-Left Difference in Visual Field Defect in the Eyes with Untreated Normal Tension Glaucoma
por: Moroi, Haruka, et al.
Publicado: (2018)

A Case of Herpes Zoster Ophthalmicus With Multiple Delayed Ocular Complications
por: Takai, Yasuyuki, et al.
Publicado: (2023)

Comparison of Latanoprost/Timolol with Carbonic Anhydrase Inhibitor and Dorzolamide/Timolol with Prostaglandin Analog in the Treatment of Glaucoma
por: Inoue, Kenji, et al.
Publicado: (2014)

Short-Term Efficacy and Safety of Switching from a Latanoprost/Timolol Fixed Combination to a Latanoprost/Carteolol Fixed Combination
por: Inoue, Kenji, et al.
Publicado: (2020)

Normal-tension glaucoma (Low-tension glaucoma)
por: Anderson, Douglas R
Publicado: (2011)

Travoprost in the management of open-angle glaucoma and ocular hypertension
por: Denis, Philippe, et al.
Publicado: (2007)

Long-Term Effectiveness and Safety of Tafluprost, Travoprost, and Latanoprost in Korean Patients with Primary Open-Angle Glaucoma or Normal-Tension Glaucoma: A Multicenter Retrospective Cohort Study (LOTUS Study)
por: Kim, Joon-Mo, et al.
Publicado: (2021)

Efficacy and safety of a switch to latanoprost 0.005% + timolol maleate 0.5% fixed combination eyedrops from latanoprost 0.005% monotherapy
por: Inoue, Kenji, et al.
Publicado: (2012)

Travoprost Liquid Nanocrystals: An Innovative Armamentarium for Effective Glaucoma Therapy
por: El-Gendy, Mohamed A., et al.
Publicado: (2023)

New directions in the treatment of normal tension glaucoma
por: Song, Brian J, et al.
Publicado: (2014)

Update on Normal Tension Glaucoma
por: Mallick, Jyotiranjan, et al.
Publicado: (2016)

Comparison of OCT and HRT Findings Among Normal, Normal Tension Glaucoma, and High Tension Glaucoma
por: Shin, In Ha, et al.
Publicado: (2008)

Predicting the development of normal tension glaucoma and related risk factors in normal tension glaucoma suspects
por: Park, Hae-Young Lopilly, et al.
Publicado: (2021)

Association between Optic Nerve Head Microcirculation and Macular Ganglion Cell Complex Thickness in Eyes with Untreated Normal Tension Glaucoma and a Hemifield Defect
por: Anraku, Ayako, et al.
Publicado: (2017)

Serum free fatty acids levels not associated with normal tension glaucoma
por: Yuki, Kenya, et al.
Publicado: (2010)

Efficacy and Safety of Switching from Tafluprost to a Tafluprost/Timolol Fixed Combination in Patients With Primary Open-Angle Glaucoma
por: Inoue, Kenji, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_cdu1kdk59qo1cgtu2554goj1l9